Klaus Bühler

No ORCID on file · 6 papers in corpus
other 2023
Gynecologic and obstetric investigation ·doi:10.1159/000530360

OBJECTIVES: The aim of the study was to evaluate dosing of recombinant human luteinizing hormone (r-hLH) or human menopausal gonadotrophin (hMG)-derived medications with LH activity in ovarian stimulation (OS) cycles for in vitro fertilizat…

article 2023
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-2061-6845

Introduction Endometriosis significantly reduces patients' quality of life and is additionally a burden on healthcare and social security systems. There are currently no quality indicators for the treatment of endometriosis. The care of pat…

other 2022
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2022.02.002

This was a retrospective real-world evidence analysis of the costs per live birth for reference recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG-HP), based o…

article 2020
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05479-5

PurposeThis study was undertaken to evaluate the prevalence of endometriosis in infertile women of couples with non-male factor infertility.MethodsA retrospective validation analysis was carried out of consecutive women of infertile couples…

article 2020
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-1068-9260

Endometriosis affects a significant number of young premenopausal women. Quite apart from the medical challenges, endometriosis is a relevant burden for healthcare and social security systems. Standardized quality indicators for the treatme…

article 2019
Archives of gynecology and obstetrics ·doi:10.1007/s00404-019-05337-z

PurposeTo determine the influence of endometriosis on the ovarian response during controlled ovarian hyperstimulation measured by number of oocytes retrieved and the follicular output rate (FORT).MethodsA retrospective, single center study …